FDA Drug Application (201917) for INCIVEK by VERTEX PHARMS

Back to FDA Applications sponsored by VERTEX PHARMS

Application Number201917
Product Number001
FormTABLET;ORAL
Dosage375MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameINCIVEK
Active IngredientTELAPREVIR



Back to FDA Applications sponsored by VERTEX PHARMS